Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
D000814:Aniline Compounds / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006452:Hemoglobinometry; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D010101:Oxygen Consumption; D005082:Physical Exertion; D011652:Pulmonary Circulation / Q000187:drug effects*; D012146:Rest; D014655:Vascular Resistance / Q000187:drug effects
D000814:Aniline Compounds; D000959:Antihypertensive Agents; D007093:Imidazoles